Socially, Economically Disadvantaged Communities Lack Access to Buprenorphine
By Lori Solomon HealthDay Reporter
FRIDAY, Aug. 23, 2024 -- Restricted buprenorphine dispensing was most pronounced in socially and economically disadvantaged communities, according to a study published in the September issue of Drug and Alcohol Dependence Reports.
Kyle J. Moon, from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues conducted a U.S. telephone audit to measure restricted buprenorphine dispensing in community pharmacies, defined as the inability to fill a buprenorphine prescription requested by a "secret shopper." The analysis included 858 pharmacies surveyed in 473 counties.
The researchers found that pharmacies in the most ethnically segregated and economically deprived counties had 2.66 times higher odds of restricting buprenorphine dispensing versus pharmacies in the most privileged counties. Higher odds of restricting buprenorphine dispensing were also seen in pharmacies in counties with high racialized economic segregation (quintile 2 and 3; adjusted odds ratio [aOR], 3.09 [95 percent confidence interval (CI), 1.7 to 5.59] and 2.11 [95 percent CI, 1.17 to 3.98], respectively). Similar patterns were seen for economic segregation (aOR, 2.18; 95 percent CI, 1.21 to 3.99). However, the pattern did not hold for ethnic (aOR, 0.59; 95 percent CI, 0.34 to 1.05) or racial (aOR, 0.61; 95 percent CI, 0.35 to 1.07) segregation alone.
"These findings have critical policy implications, in that interventions must aim to strengthen capacity in both prescribing and dispensing to achieve equitable access to treatment," the authors write. "Against the backdrop of a worsening overdose crisis, multilevel interventions are sorely needed to address persistent barriers to medications for opioid use disorder and advance pharmacoequity."
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Previous Estimates of Illicit Opioid Use in the United States Underreported
WEDNESDAY, May 14, 2025 -- Illicit opioid use may be higher than previously reported in the United States, according to a study published online May 9 in JAMA Health...
Rates of Fentanyl Nonfatal Overdose ED Visits Rose Through Third Quarter of 2023
WEDNESDAY, May 14, 2025 -- From 2020 to 2023, there was an increase in the rates of fentanyl-involved nonfatal overdose emergency department visits, according to research...
Nearly 19 Million Children Live Under Same Roof as Parent With Substance Use Disorder
TUESDAY, May 13, 2025 -- In 2023, nearly 19 million children in the United States were estimated to be living in a household with at least one parent or primary caregiver with a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.